期刊文献+

CD1d四聚体检测NKT细胞 被引量:2

原文传递
导出
摘要 目的:建立一种检测小鼠NKT细胞的方法。方法:首先将α-GalCer负载于空的CD1d四聚体上。将α-GalCer溶于1000mL/L的DMSO中,配成浓度为0.1g/L,之后震荡α-GalCer液,37℃,12h,用之前超声水浴37℃,10min,取12mol/L的上述α-GalCer液加入到1mol/L的四聚体溶液中,将上述二者的混合液37℃,避光,孵育24~48h。然后应用流式细胞术(FCM)检测正常的和腹腔注射α-GalCer5μg3d后的小鼠的脾脏及骨髓中共表达α-GalCer/CD1d四聚体及CD3的NKT细胞。结果:在正常小鼠脾脏及骨髓的淋巴细胞中NKT细胞的比例分别为1.2%和1.6%;腹腔注射α-GalCer5μg3d后小鼠脾脏的淋巴细胞中NKT细胞有轻度的增加,比例为2%和2.7%。结论:CD1d四聚体是检测小鼠NKT细胞的有效工具。
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第1期82-83,共2页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(30670898)
  • 相关文献

参考文献6

  • 1Godfrey DI, Macdonald HR, Kronenberg M, et al. NKT cells: what's in a name? [J]. Nat Rev Immunol, 2004, 4(3) : 231 -237.
  • 2Watarai H, Nakagawa R, Omori-Miyake M, et al. Methods for detection, isolation and culture of mouse and human invariant NKT cells [ J ]. Nat protocols, 2008, 1 (3) : 70 - 78.
  • 3Ikarashi Y, Akira Iizuka A, Heike Y, et al. Cytokine production and migration of in vitro-expanded NK1.1 - invariant Vetl4 natural killer T ( Vcd4i NKT) cells using α-galactosylceramide and IL-2 [ J ]. lmmu nol Lett, 2005, 101(2): 160- 167.
  • 4万建勣,曾耀英,何贤辉,徐丽慧,蔡小嫦.正常人外周血TCRVα24^+NKT细胞体外活化特性观察[J].中国病理生理杂志,2002,18(7):774-777. 被引量:3
  • 5Sun Y, Tawara I, Toubail T, et al. Pathophysiology of acute graft-vshost disease : recent advances [ J ]. Transl Res, 2007, 150 (4) : 197 - 214.
  • 6刘景华,于力.NKT细胞研究进展[J].细胞与分子免疫学杂志,2008,24(2):194-196. 被引量:18

二级参考文献23

  • 1Godfrey DI, Macdonald HR, Kronenberg M, et al. NKT cells: what's in a name? [ J ]. Nat Rev Immunol, 2004, 4 (3) : 231 - 237.
  • 2Kronenberg M, Engel I. On the road: progress in finding the unique pathway of invariant NKT cell differentiation[ J]. Curr Opin Immunol, 2007, 19(2) : 186 - 193.
  • 3Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells [J]. Nat Rev Immunol, 2002, 2(8) : 557 -568.
  • 4Baev DV, Peng XH, Song L, et al. Distinct homeostatic requirements of CD4^+ and CD4^- subsets of Vα24-invariant natural killer T cells in humans[J]. Blood, 2004, 104(13) : 4150 -4156.
  • 5Ragin M J, Sahu N, August A. Differential regulation of cytokine production by CDld-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure [ J ]. Infect Immun, 2006, 74 ( 1 ) : 282 - 288.
  • 6Zhou D, Mattner J, Cantu C, et al. Lysosomal glycosphingolipid recognition by NKT cells[J]. Science, 2004, 306(5702) : 1786 - 1799.
  • 7Porubsky S, Speak AO, Luckow B, et al. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide ( iGb3 ) deficiency [ J ]. Proc Natl Acad Sci USA, 2007, 104(14) : 5977 -5982.
  • 8Wang ZY, Kusam S, Munugalavadla V, et al. Regulation of Th2 cytokine expression in NKT cells : unconventional use of Stat6, GATA-3, and NFAT21[J]. J Immunol, 2006, 176(2): 880 -888.
  • 9Lee PT, Benlagha K, Teyton L, et al. Distinct functional lineages of human Vα24 natural killer T cells[J]. J Exp Med, 2002, 195(5) : 637 - 641.
  • 10Thomas SY, Hou R, Boyson JE, et al. CDld-restricted NKT cells express a chemokine receptor profile indicative of Th1 -type inflammatory homing cells[J]. J Immunol, 2003, 171 (5) : 2571 -2580.

共引文献19

同被引文献24

  • 1KOCH M,STRONGE V S,SHEPHERD D. The crystal structure of human CD1d with and without α-galactosylceramide[J].Nature Immunology,2005,(08):819-826.
  • 2SCHRANTZ N,SAGIV Y,LIU Y. The Niemann-Pick type C2 protein loads isoglobotrihexos-ylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells[J].Journal of Experimental Medicine,2007,(07):841-852.
  • 3ZAJONC D M,ELSLIGER M A,TEYTON L. Crystal structure of CD1a in complex with a sulfati-de self antigen at a resolution of 2.15A[J].Nature Immunology,2003,(08):808-815.
  • 4LAWTON A P,PRIGOZY T I,BROSSAY L. The mouse CD1d cytoplasmic tail mediates CD1d trafficking and antigen presentation by adaptor protein 3-dependent and-independent mechanisms[J].Immunology,2005,(06):3179-3186.
  • 5KANG S J,CRESSWELL P. Regulation of intracellular trafficking of human CD1d by association with MHC class Ⅱ molecules[J].EMBO Journal,2002,(07):1650-1660.doi:10.1093/emboj/21.7.1650.
  • 6HONEY K,BENLAGHA K,BEERS C. Thymocyte expression of cathepsin L is essential for N-KT cell development[J].Nature Immunology,2002,(11):1069-1074.doi:10.1038/ni844.
  • 7THIERRY M,ANDREW J,JAMES P. A molecular basis for NKT cell recognition of CD1d-self-antigen[J].Immunity,2011,(05):315-326.
  • 8SHARIF S,ARREAZA G A,ZUCKER P. Activation of natural killer T cells by alpha-galactosyl-ceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes[J].Nature Medicine,2010,(05):1057-1062.
  • 9LEE A,FARRAND K J,DICKGREBER N. Novel synthesis of [alpha]-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity[J].Carbohydrate Research,2006,(17):2785-2798.doi:10.1016/j.carres.2006.09.006.
  • 10PRIGOZY T I,NAIDENKO O,QASBA P. Glycolipid antigen processing for presentation by CD1d molecules[J].Science,2001,(5504):664-667.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部